Hepatitis B remains one of the most persistent viral infections worldwide, affecting hundreds of millions of people chronically according to global health estimates. While modern antiviral therapy such as tenofovir and entecavir has significantly improved outcomes, many patients seek adjunctive support for liver protection, immune balance, and relief from fatigue and digestive weakness that may persist despite viral suppression.

In classical Ayurvedic literature, hepatitis-like presentations are described under yakrit roga (liver disorders) and kamala (jaundice conditions). Kamala is understood as a disorder arising from aggravated pitta, particularly ranjaka pitta located in the liver and blood tissues (rakta dhatu), leading to impaired bile metabolism and systemic discoloration. Clinical features such as yellowing of the eyes and skin, dark urine, pale stools, fatigue, and loss of appetite closely resemble hepatitis presentations.

Within the Ayurvedic framework, the liver (yakrit) is considered a central organ for blood purification and pitta regulation. Management focuses on three coordinated objectives: pacifying aggravated pitta, protecting hepatic tissue, and supporting functional regeneration of liver metabolism. Two herbs most commonly emphasized in this context are katuki (Picrorhiza kurroa) and bhumyamalaki (Phyllanthus niruri).

Katuki (Picrorhiza kurroa): The Bitter Hepatoprotective Herb

Katuki, also known as kutki, is a perennial Himalayan herb traditionally valued for its intensely bitter taste (tikta rasa), which is considered highly effective in pacifying aggravated pitta and supporting liver function. It is primarily used in conditions involving impaired digestion, toxin accumulation, and hepatic sluggishness.

Classical Positioning

Traditional Ayurvedic nighantus describe katuki as beneficial for liver and spleen disorders, fever conditions, and pitta imbalance. It is regarded as a strong bitter herb that supports bile regulation, digestion, and metabolic cleansing processes associated with yakrit function.

Its bitter compounds, mainly iridoid glycosides such as picrosides, are considered responsible for its hepatoprotective and antioxidant activity, supporting its traditional use in liver-related disorders.

Modern Pharmacological Understanding

Experimental and clinical literature has reported hepatoprotective, antioxidant, and anti-inflammatory activity of Picrorhiza kurroa. These effects are attributed to modulation of oxidative stress pathways and support of endogenous antioxidant systems involved in hepatic protection.

Clinical observations in viral hepatitis contexts have noted improvements in liver enzyme patterns and bilirubin metabolism when katuki-based preparations are used as supportive therapy alongside standard medical care.

Dosage and Preparation

Katuki is traditionally administered in several forms depending on patient tolerance and clinical condition:

• Churna (powder): 1–3 grams twice daily with warm water or honey.
• Extract tablets (Ghana Vati): 250–500 mg twice daily for those sensitive to bitter taste.
• Arogyavardhini Vati: 250–500 mg twice daily, used under careful supervision due to its mineral content and multi-herb composition.

Bhumyamalaki (Phyllanthus niruri): The Viral-Targeted Liver Herb

Bhumyamalaki is a small tropical herb widely used in Ayurveda for liver disorders, jaundice conditions, and urinary regulation. It is traditionally classified as pitta-pacifying and supportive in yakrit and spleen-related disorders.

Traditional Context

Bhumyamalaki is described in Ayurvedic texts as beneficial in conditions involving excess pitta, impaired bile flow, and hepatic dysfunction. It is valued for its cooling, detoxifying, and supportive effects on liver metabolism.

Research and Experimental Insights

Experimental studies on Phyllanthus species have reported antiviral activity against hepatitis B virus replication pathways, including inhibition of viral polymerase activity and modulation of viral antigen expression in infected liver cells.

Variability in clinical outcomes has been observed across studies due to differences in plant species, extract preparation, and treatment duration, but hepatoprotective and liver-supportive effects are consistently reported in experimental literature.

Dosage and Preparation

• Fresh juice (swarasa): 10–20 ml twice daily.
• Powder: 3–5 grams twice daily with water.
• Standardized extract: 500 mg twice daily.
• Decoction (kwatha): 50–100 ml twice daily.

The Synergy of Katuki and Bhumyamalaki

In Ayurvedic therapeutics, synergistic combinations (yoga) are designed to address multiple dimensions of disease simultaneously. Katuki and bhumyamalaki complement each other in hepatic disorders by supporting different functional pathways.

Together, these herbs are traditionally used to support liver function, regulate pitta imbalance, and assist in maintaining metabolic stability in chronic hepatic conditions when used alongside appropriate medical supervision.

Clinical Protocol: Supportive Ayurvedic Framework for Chronic Hepatitis B

This protocol represents a traditional Ayurvedic supportive approach used alongside standard antiviral therapy. Individualization based on liver function, viral load, and overall health status is essential.

Phase 1: Assessment and Baseline (Week 1)

Baseline evaluation includes liver function tests (ALT, AST, bilirubin profile, albumin), HBV DNA levels, HBeAg status, complete blood count, and imaging such as ultrasound or FibroScan when available.

Ayurvedic assessment focuses on prakriti (constitution), agni (digestive strength), and signs of pitta-rakta imbalance such as fatigue, digestive irregularity, and skin discoloration.

Phase 2: Active Supportive Care (Months 1–6)

• Katuki churna: 2 grams twice daily before meals with warm water
• Bhumyamalaki churna: 3 grams twice daily after meals
• Aloe vera juice: 15–20 ml once daily on an empty stomach
• Guduchi (Tinospora cordifolia): 500 mg twice daily as an immunomodulatory herb

This herbal protocol is used as an adjunct to antiviral therapy and is not intended to replace prescribed medical treatment. Coordination with the treating physician is essential.

Phase 3: Monitoring

Liver function tests and viral markers are monitored periodically to assess disease progression and hepatic response. Clinical signs such as appetite, energy levels, and digestion are also evaluated as part of overall assessment.

Phase 4: Maintenance

After initial improvement, lower maintenance doses may be used under supervision to support ongoing liver health and metabolic balance.

Dietary Framework for Liver Support

Diet plays a central role in Ayurvedic management of hepatic disorders. A pitta-pacifying dietary approach is recommended.

• Recommended: Bitter vegetables, leafy greens, mung dal, barley, pomegranate, grapes, and lightly prepared warm foods.
• Avoid: Alcohol, excessively spicy foods, deep-fried foods, processed foods, and excessive sour or fermented items.
• Carrier substances: Warm water or buttermilk may be used to support herbal absorption and digestion.

Safety Considerations

Herbal interventions must be used cautiously in chronic liver disease. Dose adjustments are required in advanced liver impairment. Immunomodulatory herbs should be used carefully in patients on immunosuppressive therapy. Katuki and bhumyamalaki are not recommended during pregnancy. Professional supervision is essential in all cases involving chronic hepatitis B.

Clinical Perspective

Chronic hepatitis B requires lifelong monitoring and coordinated care. Ayurvedic herbal support may assist in maintaining liver function, digestive strength, and overall well-being when used alongside antiviral therapy and regular medical supervision. Consistency, individualized dosing, and integration with modern hepatology provide the most balanced approach.

Medical Disclaimer: This content is for educational purposes only. Hepatitis B is a serious medical condition requiring supervision by qualified healthcare professionals. Ayurvedic interventions should be used only as supportive care alongside standard treatment and under expert guidance.

This article does not diagnose or treat disease. Always consult a qualified physician before starting or modifying any treatment.

References

1. World Health Organization
2. En (en.wikipedia.org)
3. En (en.wikipedia.org)
4. En (en.wikipedia.org)

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver conditions worldwide, with recent global estimates placing adult prevalence around one-third of the population. Conventional care remains centered on sustained dietary change, weight reduction where appropriate, exercise, cardiometabolic risk control, and medical monitoring. Ayurveda offers a complementary framework built around Agni, Kapha, Meda dhatu, Yakrit support, digestive correction, and disciplined daily routine.

This protocol presents an integrative Ayurvedic approach for fatty liver management while keeping conventional assessment in place. It is not a substitute for diagnosis, imaging, liver-function testing, diabetes care, lipid management, or hepatology follow-up when indicated.

Understanding NAFLD Through the Ayurvedic Lens

Ayurveda does not describe NAFLD as a modern diagnostic entity, but the clinical pattern can be approached as a Santarpana-type disorder involving excess nourishment, Kapha-Meda accumulation, impaired Agni, sluggish tissue metabolism, and obstruction of channels. The liver is addressed through Yakrit-centered assessment while also correcting digestion, bowel regularity, diet, activity, and metabolic load.

1. Nidana: Excessive intake of sweet, heavy, oily, refined, and repeatedly fried foods; overeating; alcohol intake; inactivity; irregular sleep; and a sedentary routine.
2. Kapha-Meda vriddhi: Heavy and unctuous dietary patterns encourage Kapha dominance and excessive Meda accumulation.
3. Agni and Meda-dhatvagni mandya: Weak digestive and tissue metabolism leads to incomplete processing of nutrients and a tendency toward accumulation.
4. Ama and srotorodha: Metabolic residue and channel obstruction contribute to heaviness, sluggishness, bloating, coated tongue, fatigue, and poor post-meal clarity.
5. Yakrit involvement: The treatment focus becomes reducing metabolic burden, supporting bile and digestion, restoring bowel regularity, and improving overall metabolic resilience.

From this perspective, the aim is not simply to “cleanse the liver,” but to reverse the conditions that keep fat accumulating: excess Kapha, weak Agni, poor movement, unsuitable food, and uncorrected cardiometabolic risk.

Primary Herbs for Ayurvedic NAFLD Management

Ayurvedic herbs for fatty liver are best selected by constitution, digestive strength, liver enzymes, medications, bowel pattern, and the presence or absence of inflammation, edema, reflux, gallbladder disease, pregnancy, kidney disease, or advanced liver disease. The herbs below are commonly discussed because their classical profiles and contemporary pharmacological literature align with liver-metabolic support, but they should not be combined casually or used as a replacement for medical care.

Kutki / Katuka (Picrorhiza kurroa)

Kutki, called Katuka in the Ayurvedic Pharmacopoeia of India, is described as bitter-pungent in taste, light in quality, hot in potency, pungent in post-digestive effect, and associated with Dipana, Bhedana, Pittahara, and use in conditions such as Kamala. This makes it relevant when fatty liver presents with sluggish digestion, poor appetite, constipation tendency, heaviness, and a need for bitter metabolic correction.

Picrorhiza contains picrosides and kutkoside-rich fractions that are widely discussed for hepatoprotective activity in experimental and clinical liver literature. In practice, Kutki is a strong herb; excessive or unsuitable use may aggravate loose stools, weakness, or irritation, so it belongs in a practitioner-guided plan rather than daily self-prescription.

Bhumyamalaki / Tamalaki (Phyllanthus fraternus; Phyllanthus niruri synonym in API)

Bhumyamalaki, listed in the Ayurvedic Pharmacopoeia under Tamalaki, is described with sweet, bitter, and astringent taste; light and dry qualities; cooling potency; sweet post-digestive effect; and Pittashamaka, Mutrala, Rocana, and Daha-shamana actions. This profile is useful when fatty liver is accompanied by heat, sour belching, burning, urinary irritation, or a Pitta-Kapha presentation.

The Phyllanthus group contains compounds such as phyllanthin, and preclinical NAFLD models have examined Phyllanthus niruri extracts for effects on hepatic fat accumulation. Clinically, Bhumyamalaki is most appropriately used as a cooling liver-digestive support herb, especially when aggressive heating formulas are not suitable.

Kalmegh (Andrographis paniculata)

Kalmegh is valued for its intensely bitter profile and is often used in liver-digestive practice where Kapha, sluggish appetite, coated tongue, and heaviness are prominent. Its major compound andrographolide has been examined in experimental hepatic steatosis models, including work related to fatty-acid uptake and inflammatory pathways.

Because Kalmegh is very bitter and drying, it is not appropriate for every fatty liver patient. It is generally avoided in pregnancy and used cautiously in people with marked Vata depletion, very low appetite from weakness, or sensitivity to bitter herbs.

Punarnava (Boerhavia diffusa)

Punarnava is described in the Ayurvedic Pharmacopoeia as sweet, bitter, and astringent in taste; dry in quality; hot in potency; sweet in post-digestive effect; and associated with Shothahara, Mutrala, Anulomana, and Vata-Shleshmahara actions. This makes it especially relevant when fatty liver is accompanied by swelling, water retention, heaviness, sluggish bowels, or a Kapha-dominant presentation.

Punarnava contains punarnavine and appears in classical formulations such as Punarnavasava and Punarnavadi Mandura. In a fatty liver plan, it is usually an adjunct rather than the central herb, particularly when fluid retention or metabolic heaviness is part of the picture.

Arogyavardhini Gutika / Vati

Arogyavardhini is a classical herbo-mineral formulation used in Ayurvedic practice for liver-metabolic and digestive indications. Its classical composition includes purified mineral components along with herbs such as Triphala, Guggulu, Chitraka, Kutki, and Nimba-based processing, depending on the authoritative formulation reference followed by the manufacturer.

Because Arogyavardhini contains Rasaushadhi components, including purified mercury and sulfur along with bhasma ingredients in the traditional formula, it must be used only under qualified Ayurvedic supervision. It should be purchased only from manufacturers that provide batch-level quality testing for identity, microbial safety, arsenic, lead, mercury, cadmium, and other contaminants.

Important safety note: Do not self-prescribe Arogyavardhini, high-dose Kutki, Kalmegh, or multi-herb liver formulas if you are pregnant, breastfeeding, taking anticoagulants, taking diabetes or blood-pressure medicines, have gallstones, kidney disease, active hepatitis, cirrhosis, jaundice, unexplained weight loss, or liver enzymes that are significantly elevated. Consult a qualified Ayurvedic practitioner and a healthcare provider before starting treatment.

Comparative Herb Analysis for Fatty Liver

The table below summarizes how commonly used Ayurvedic herbs fit into a fatty liver protocol. Classical dose ranges from pharmacopoeial sources refer to crude drug forms and are not the same as modern extracts; actual dosing must be individualized.

12-Week Ayurvedic Fatty Liver Protocol

A responsible Ayurvedic fatty liver protocol proceeds in phases: first reduce digestive burden and Ama, then introduce targeted herbs, then consolidate lifestyle changes so improvement is sustainable. The timeline below is educational and should be adapted after assessment of prakriti, vikriti, liver enzymes, ultrasound or FibroScan findings, medications, glucose control, lipid profile, and bowel pattern.

Phase 1: Agni and Ama Correction (Weeks 1-3)

The first phase reduces the load that keeps Kapha-Meda accumulation active. It emphasizes meal timing, light food, bowel regularity, warm hydration, and removal of the most liver-burdening habits before strong herbs are introduced.

• Meal rhythm: Eat at consistent times, avoid grazing, and keep dinner lighter than lunch.
• Food simplification: Remove alcohol, sugary drinks, refined flour, deep-fried foods, packaged snacks, heavy desserts, and excess dairy fats.
• Warm digestion support: Sip warm water through the day; use mild ginger, cumin, coriander, or fennel infusions according to tolerance.
• Bowel support: Triphala may be considered when constipation is present, but the form and dose should match bowel sensitivity.
• Agni support: Trikatu is considered only in clear Kapha-type sluggishness and avoided when reflux, burning, ulcers, bleeding tendency, or Pitta aggravation is present.

Phase 2: Targeted Yakrit-Meda Support (Weeks 4-9)

The second phase introduces physician-selected botanicals or formulations after digestion, bowel movement, and diet have stabilized. The goal is to reduce Kapha-Meda load while supporting liver function without irritating the patient or masking worsening disease.

• Kutki-centered approach: Considered when heaviness, constipation tendency, poor appetite, and Kapha-Meda accumulation are dominant.
• Bhumyamalaki-centered approach: Considered when heat, sourness, burning, Pitta signs, or intolerance to hot herbs is present.
• Punarnava adjunct: Considered when swelling, water retention, heaviness, or sluggish elimination accompanies fatty liver.
• Kalmegh adjunct: Considered in selected Kapha-heavy presentations where a strong bitter approach is appropriate.
• Arogyavardhini option: Considered only under qualified supervision, with product testing and monitoring, and avoided in pregnancy, children, advanced liver disease, or uncertain product quality.

Phase 3: Consolidation and Maintenance (Weeks 10-12)

The third phase avoids the common mistake of stopping treatment as soon as energy improves or liver enzymes begin to move in the right direction. The emphasis shifts from strong correction to sustainable food, activity, sleep, weight management, and repeat testing.

• Continue the diet pattern: Keep meals light, high in fiber, moderate in calories, and centered on legumes, vegetables, bitter greens, and appropriate grains.
• Reduce unnecessary intensity: Strong bitter or purgative approaches should be tapered or reassessed rather than continued indefinitely.
• Build muscle and insulin sensitivity: Add resistance training if medically safe, because improved muscle metabolism supports fatty liver reversal.
• Repeat monitoring: Liver enzymes, lipid profile, glucose markers, waist measurement, and imaging should guide whether the plan is working.

Dietary Modifications for Fatty Liver

Ayurvedic dietary therapy for fatty liver centers on reducing Kapha-aggravating and Meda-promoting foods while emphasizing light, warm, fiber-rich, bitter, astringent, and metabolically supportive meals. The most effective diet is not a short cleanse; it is a repeatable pattern that creates a steady calorie deficit when weight loss is needed and improves insulin resistance.

Foods to Emphasize

The best foods are those that are light enough to digest, high enough in fiber to improve satiety, and compatible with a Kapha-Meda reduction plan. Classical food choices such as barley and horse gram are especially relevant when tolerated.

• Light grains: Barley (Yava), old rice in moderation, millets, and other whole grains suited to digestion and glucose status.
• Legumes: Mung dal, masoor dal, and horse gram (Kulattha) when digestion is strong enough.
• Bitter and astringent vegetables: Bitter gourd, fenugreek leaves, leafy greens, ridge gourd, bottle gourd, and non-starchy vegetables.
• Digestive spices: Turmeric, cumin, coriander, fennel, dry ginger, black pepper, and ajwain, selected according to Pitta tolerance.
• Protein support: Adequate vegetarian or non-vegetarian protein as medically and culturally appropriate, with preference for lighter preparations over fried or creamy dishes.
• Beverages: Warm water, unsweetened herbal infusions, and avoidance of sweetened juices or cold sugary drinks.

Foods to Avoid or Minimize

The most important dietary restriction is not exotic; it is consistent reduction of the foods that drive excess calories, insulin resistance, triglycerides, and Kapha-Meda accumulation. Alcohol avoidance is especially important in fatty liver care.

• Alcohol in any form unless specifically cleared by a physician.
• Refined sugar, sweetened beverages, packaged sweets, bakery foods, and frequent desserts.
• Deep-fried foods, reheated oils, fast food, trans fats, and heavy snack foods.
• Large portions of white rice, refined flour, noodles, pizza, and other low-fiber starches.
• Excess cheese, cream, butter, heavy dairy sweets, and high-fat late dinners.
• Frequent late-night eating, overeating, and snacking without hunger.
• Excess sweet fruits and fruit juices when triglycerides, obesity, or insulin resistance are present.

The Role of Virechana Therapy

Virechana is a physician-supervised Panchakarma procedure involving therapeutic purgation after appropriate preparation. In an Ayurvedic fatty liver protocol, it may be considered for suitable patients with Pitta-Kapha-Meda features, but it is not a home laxative routine and should not be reduced to “detox.”

Classical Panchakarma sequencing requires assessment, preparation, oleation or other preparatory measures when indicated, supervised purgation, and post-procedure diet. It is avoided or postponed in pregnancy, frailty, dehydration, acute illness, active hepatitis, advanced cirrhosis, bleeding risk, severe anemia, uncontrolled diabetes, severe kidney disease, or when the patient cannot be monitored properly.

The Gut-Liver Axis: An Ayurvedic Perspective

Modern hepatology recognizes a close relationship between intestinal function and liver health through the portal circulation, microbiome, gut permeability, bile-acid metabolism, inflammation, and metabolic signaling. Ayurveda approaches this connection through Agni, Grahani function, bowel regularity, Ama reduction, and the principle that poorly digested food burdens later tissue metabolism.

This is why the protocol begins with digestion instead of starting immediately with strong liver herbs. Triphala, warm water, meal timing, lighter dinners, legumes, fiber-rich vegetables, and reduction of refined carbohydrates all support the gut-liver relationship in practical ways. When bloating, constipation, diarrhea, reflux, or food intolerance is prominent, those problems should be corrected as part of fatty liver care.

Prakriti-Based Protocol Modifications

Prakriti and vikriti assessment prevent a one-size-fits-all approach. Kapha-dominant patients usually need stronger emphasis on calorie reduction, activity, light grains, legumes, bitter vegetables, and avoidance of day sleeping. Pitta-dominant patients often require cooling bitter support, careful spice selection, and avoidance of aggressive heating formulas. Vata-dominant patients need a gentler plan so weight loss and bitter herbs do not create depletion, insomnia, anxiety, constipation, or weakness.

For mixed presentations, the practitioner should prioritize the most active pathology: high triglycerides and obesity point toward Kapha-Meda correction; burning and inflammation point toward Pitta balance; frailty and irregular digestion point toward Vata protection before stronger reduction methods.

Monitoring and Conventional Integration

Ayurvedic treatment for fatty liver should be integrated with medical monitoring. Baseline and follow-up assessment help distinguish simple steatosis from steatohepatitis, fibrosis, medication-related liver injury, viral hepatitis, autoimmune liver disease, biliary obstruction, alcohol-related liver disease, or advanced cirrhosis.

• Liver function tests: ALT, AST, GGT, alkaline phosphatase, bilirubin, albumin, and INR when clinically indicated.
• Metabolic markers: Fasting glucose, HbA1c, fasting insulin when appropriate, lipid profile, blood pressure, and waist circumference.
• Imaging: Ultrasound, FibroScan, or other physician-advised imaging to assess steatosis and fibrosis risk.
• Body composition: Weight, BMI, waist-to-height ratio, and strength or activity capacity.
• Medication review: Diabetes medicines, lipid-lowering drugs, hepatotoxic medicines, supplements, and alcohol intake should be reviewed openly with the healthcare provider.

When to Refer to a Hepatologist

Specialist evaluation is needed when there is jaundice, ascites, vomiting blood, black stools, confusion, easy bleeding, severe fatigue with weight loss, persistent or marked elevation of liver enzymes, suspected fibrosis, low platelets, abnormal INR, high bilirubin, positive viral hepatitis tests, autoimmune markers, or worsening imaging. Referral is also appropriate when fatty liver coexists with diabetes, obesity, high triglycerides, chronic kidney disease, or cardiovascular disease.

Integration is the safest model: Ayurvedic treatment can support diet, digestion, lifestyle, and carefully selected herbal care, while conventional medicine tracks fibrosis risk, metabolic complications, and warning signs.

Lifestyle Recommendations

Lifestyle is the central medicine for fatty liver. Herbs may support the process, but sustained improvement usually requires daily movement, weight reduction where needed, improved sleep, less sitting, and regular meals that lower metabolic overload.

• Exercise: Aim for at least 150 minutes per week of moderate aerobic activity, such as brisk walking, cycling, or swimming, unless medically restricted.
• Resistance training: Add strength training two to three times weekly to improve muscle mass, insulin sensitivity, and long-term weight maintenance.
• Walking after meals: A 10- to 15-minute walk after larger meals can help reduce post-meal sluggishness and support glucose handling.
• Sleep rhythm: Maintain consistent sleep and wake times; avoid late dinners and heavy nighttime snacking.
• Avoid prolonged sitting: Break sitting every 30 to 60 minutes with standing, walking, or light mobility.
• Udvartana: Dry powder massage may be used as a supportive Kapha-reducing practice under guidance, especially when heaviness and lethargy are prominent.
• Dinacharya: A consistent morning routine supports regular elimination, appetite rhythm, and adherence to food and exercise changes.

Safety, Expectations, and Realistic Outcomes

Grade I fatty liver may improve with consistent weight management, diet, exercise, and metabolic correction over several months, while more advanced steatosis, suspected NASH, or fibrosis requires longer follow-up and closer medical supervision. Liver enzymes can improve before liver fat or fibrosis risk fully resolves, so symptom improvement alone should not be treated as proof of recovery.

Use Ayurvedic herbs and herbo-mineral formulations responsibly. Product quality varies, and some Ayurvedic preparations have been found to contain unsafe levels of lead, mercury, arsenic, or other contaminants. Choose tested products, disclose all supplements to your healthcare provider, and stop self-treatment if jaundice, severe abdominal pain, dark urine, pale stools, itching, vomiting, bleeding, confusion, or sudden worsening fatigue occurs.

This article is for educational purposes only. Consult a qualified Ayurvedic practitioner and a licensed healthcare provider for personalized diagnosis, herb selection, dosing, contraindications, laboratory monitoring, and integration with conventional NAFLD care.

References

1. Global incidence and prevalence of nonalcoholic fatty liver disease (2023), PubMed Central
2. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review (2023), PubMed Central
3. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (2016), PubMed Central
4. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (2023), PubMed Central
5. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine (2023), PubMed Central
6. NCCIH
7. Ayurvedic Pharmacopoeia of India
8. Pharmacological and Clinical Efficacy of Picrorhiza kurroa and Its Secondary Metabolites: A Comprehensive Review (2022), PubMed Central
9. Ayurvedic Pharmacopoeia of India
10. Mdpi (mdpi.com)
11. Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease (2023), PubMed Central
12. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride (1990), PubMed
13. An Ayurvedic formulation ‘Trikatu’ and its constituents (1992), PubMed
14. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
15. Efficacy of Triphala extracts on the changes of obese fecal microbiome and metabolome in the human gut model (2023), PubMed Central
16. The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC (2022), PubMed Central
17. Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis (2020), PubMed Central
18. Clinical study to evaluate the effect of Virechanakarma on serum electrolytes (2013), PubMed Central
19. Effect of Ayurveda interventions in non-alcoholic grade II fatty liver associated with obesity – A case report (2022), PubMed Central
20. Ayurvedic Pharmacopoeia of India
21. Clinical study of Arogyavardhini compound and lifestyle modification in management of metabolic syndrome: A double‑blind placebo controlled randomized clinical trial (2019), PubMed
22. FDA
23. Jamanetwork (jamanetwork.com)